Jack Hsu, MD
Hematology · Gainesville, FLNPI 1902867575
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Every reported general payment came from a single manufacturer, Daiichi Sankyo Inc..
Across 7 payments — averaging $381.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$3K
Across 83 payments — averaging $6736.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$540K
- Pfizer$19K
- Astellas Pharma Global Development$329
What the payments were for
- Consulting fees$1,52857%
- Travel & lodging$98337%
- Food & beverage$1596%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $2,669 |
How this compares
$2,669 in reported general payments places this provider in the 55th percentile of 79 hematology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PromactaEltrombopag Olamine | 25 | $526,481 |
| ScemblixAsciminib Hydrochloride | 11 | $253,752 |
| Lenalidomide | 21 | $246,347 |
| PrevymisLetermovir | 14 | $99,953 |
| Imatinib Mesylate | 17 | $3,111 |
| ValacyclovirValacyclovir Hcl | 78 | $2,782 |
| Oxycodone Hcl | 44 | $695 |
| Gabapentin | 30 | $420 |
| Dexamethasone | 18 | $237 |
| Pregabalin | 12 | $208 |
| Pantoprazole Sodium | 16 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $52 |
| Lorazepam | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other hematology in Gainesville
- Craig KitchensGainesville$11K
- Anita RajasekharGainesville$2K
- Ansh MehtaGainesville$450
- Zeina Al-MansourGainesville$234
- Peng LiGainesville$164
- Javier Pinilla-IbarzTampa$1.6M
- Rami KomrokjiTampa$855K
- Ahmed ZakariAltamonte Springs$383K
- Alex Mejia GarciaVero Beach$302K
- Doris HansenTampa$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.